Association between prediagnostic IgE levels and risk of glioma.
about
Inverse Association between Prediagnostic IgE Levels and the Risk of Brain Tumors: A Systematic Review and Meta-AnalysisImmune-related conditions and subsequent risk of brain cancer in a cohort of 4.5 million male US veterans.Single-nucleotide polymorphisms of allergy-related genes and risk of adult gliomaThe epidemiology of glioma in adults: a "state of the science" reviewEarly life exposures and the risk of adult gliomaAtopy and Specific Cancer Sites: a Review of Epidemiological Studies.Cohort Profile: The Janus Serum Bank Cohort in Norway.A nested case-control study of 277 prediagnostic serum cytokines and glioma.Serum immunoglobulin e and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.Association between Prediagnostic Allergy-Related Serum Cytokines and Glioma.Metabolic serum biomarkers for the prediction of cancer: a follow-up of the studies conducted in the Swedish AMORIS studyInvestigating the association between allergen-specific immunoglobulin E, cancer risk and survival.LOH in the HLA class I region at 6p21 is associated with shorter survival in newly diagnosed adult glioblastomaAssociation Between Prediagnostic Serum 25-Hydroxyvitamin D Concentration and Glioma.Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study.Pre-diagnostic serum levels of EGFR and ErbB2 and genetic glioma risk variants: a nested case-control study.Associations between allergic conditions and pediatric brain tumors in Neurofibromatosis type 1.Metabolomic screening of pre-diagnostic serum samples identifies association between α- and γ-tocopherols and glioblastoma risk.Interaction of allergy history and antibodies to specific varicella-zoster virus proteins on glioma risk.Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma.Associations between allergies and risk of hematologic malignancies: results from the VITamins and lifestyle cohort studyCirculating biomarkers of CNS tumors: an update.Exploitation of adaptive evolution in glioma treatment.Allergic conditions reduce the risk of glioma: a meta-analysis based on 128,936 subjects.AllergoOncology - the impact of allergy in oncology: EAACI position paper.The impact of body mass index and height on the risk for glioblastoma and other glioma subgroups: a large prospective cohort study.Allergy and brain tumors in the INTERPHONE study: pooled results from Australia, Canada, France, Israel, and New Zealand.MiR-126 Regulates the ERK Pathway via Targeting KRAS to Inhibit the Glioma Cell Proliferation and Invasion.Atopic conditions and brain tumor risk in children and adolescents--an international case-control study (CEFALO).Association of the interleukin-4Rα rs1801275 and rs1805015 polymorphisms with glioma risk.Socioeconomic status and glioblastoma risk: a population-based analysis.Antihistamine use and immunoglobulin E levels in glioma risk and prognosis.
P2860
Q26785944-4B77362D-D47F-4BD2-BFD5-0C3D24207510Q28383237-A0517F56-B317-432F-912F-AADFEF8EA4A0Q28384239-20835CF9-4113-4C86-BC3A-C2FB5663FF11Q28387839-8497B94F-A809-4274-A55E-A17F1D1C2A84Q28389459-2F685C4F-B974-4998-BC33-1C42296E8E41Q30249752-9F8A79CF-3A18-475D-8B76-6D897863A220Q33458121-06C3698D-8A8C-49F1-ACF8-93C5A8A07B5EQ33778545-2F8D8989-47CC-4F4A-BF07-08082B190B41Q33995287-1B96B435-7C9C-4E8C-867A-0719557BF2E5Q35767586-3648A924-B542-4861-874C-A1DC4F59A363Q35935362-D35FAAD6-C49F-4B39-87CE-BE08E262B558Q36089397-56C99DC5-1FB0-4916-A570-B76BBDB6D5F0Q36745457-2395A993-E127-4F58-B05B-2A0FAD1D8D29Q36786297-D071C0D7-1B88-4C58-B0D3-F7B89F0FB2D7Q36921260-8E1AFD9E-E978-4244-9346-D5DC0E8A159EQ37208166-6CCD46DD-A6AD-4CCA-BCA8-978D5B913F73Q37366033-E9398FA4-03A6-44EF-9A78-C67E17EBE47FQ37392903-882ADC20-9BC3-44C6-B224-DAF0DAD90E46Q37633252-47985E43-FB9C-48CB-B0EF-7AB70E853393Q37688213-F8D6901A-558F-497C-8B97-ACA5D9437CDDQ37727195-506E7B30-2A19-4B30-943C-EE9363A0EF17Q38095109-D3BE5C53-F973-49BC-94BE-BFF96BB01D11Q38131489-4DD6A4AB-F2A2-4AE4-B56A-D9BE4533F576Q38402068-F31E0A93-22BE-4479-B2D7-16EA5D12274FQ38776716-FACA7B48-0FBE-4030-9B88-76C6D7041C1EQ39045776-5567BEB0-47FD-4F35-AC4F-9150678ADDEFQ40256164-04B4F5B4-F467-40AC-97FE-48CB73D1F3C0Q40999025-CE7D45E8-EB21-4C02-B814-4468A8C4A343Q45278583-595DBFF1-A33D-44BC-A8C3-5D4F2DAB346FQ45908118-7F7507A1-E8AD-426F-90CB-7D250227FF44Q46227922-985CED16-89DA-414C-A827-1E5B423A91B6Q55461495-F45D7233-A130-4663-A58C-733A676ED7B5
P2860
Association between prediagnostic IgE levels and risk of glioma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Association between prediagnostic IgE levels and risk of glioma.
@ast
Association between prediagnostic IgE levels and risk of glioma.
@en
type
label
Association between prediagnostic IgE levels and risk of glioma.
@ast
Association between prediagnostic IgE levels and risk of glioma.
@en
prefLabel
Association between prediagnostic IgE levels and risk of glioma.
@ast
Association between prediagnostic IgE levels and risk of glioma.
@en
P2093
P2860
P356
P1476
Association between prediagnostic IgE levels and risk of glioma.
@en
P2093
Judith Schwartzbaum
Linda Karavodin
Liv T N Osnes
Tom Borge Johannesen
Tom K Grimsrud
P2860
P304
P356
10.1093/JNCI/DJS315
P407
P577
2012-08-01T00:00:00Z